Meg Wood is a venture capital business development executive with experience creating emerging growth strategies for portfolio investment. As the Managing Director of NYBC Ventures, Meg oversees deal execution and management. Board Observer for NYBC Ventures portfolio companies Catena Biosciences and KaloCyte. Previously, Meg built and managed a $50 million fund for scientific research and innovation for a rare disease as the Vice President of Business Development at CD Ventures. She has deep experience deploying investment capital for mission-oriented fund structures. Prior to her role at CD Ventures, she held positions at MPM Capital, Tufts Medical Center and Boston Medical Center. She received Master’s degrees in social work and public health from Boston University and her BA from the College of Charleston.